The Nobel Laureate was being treated for an infection caused by prostate cancer treatment he's received for many years
Research finds an association between positive post-radiation therapy biopsy results and subsequent clinical outcomes in men with localized prostate cancer.
For the first time, scientists have discovered prostate cancer can be categorized into five different types, each with its own genetic fingerprint.
Cancer Research UK scientists have for the first time identified that there are five distinct types of prostate cancer and found a way to distinguish between them, according to a study in EBioMedicine. The findings could have important...Show More Summary
White man's risk of getting prostate cancer is approximately 1 in 8, whereas for black men the risk was 1 in 4
Through genomic profiling of 259 men with prostate cancer, scientists have identified five groups of prostate cancer with distinct DNA signatures.The discovery represents a major advance as researchers can now begin trying to tailor therapies to those subtypes. Show More Summary
Scientists have, for the first time, identified that there are five distinct types of prostate cancer and have found a way to distinguish between them, according to a landmark study.
One of only three custom Scramblers used in Jurassic World. One of its copies is with star Chris Pratt and the other is on display at Triumph’s headquarters. Proceeds will be split between four prostate cancer research groups.
Doctors to decide further treatment for Nobel Peace laureate, who has lived with prostate cancer for 15 years.
Scientists believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy. It is hoped that this new development could pave the way for more effective treatments -- allowing a lower dose of radiotherapy to be used while prolonging the lives of thousands of men.
Shift work is widespread: between approximately one in five and one in six of the working population work shifts. Now new research shows, that in fact, shift workers do not develop prostate cancer more frequently than their colleagues who work during the day.
In 2014, low-risk prostate cancer was the most common type of prostate cancer diagnosed in the United States, affecting about 150,000 patients, many of whom undergo aggressive treatment, either complete removal of the prostate or radiation. Increased radiation dose is associated with higher survival rates in men with medium- and high-risk prostate cancer, but not […]
After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.
OPKO's acquisition of Bio-Reference Labs will transform it into a lab-testing market leader.
A gene that is responsible for cancer growth plays a totally unexpected role in prostate cancer. The gene Stat3 is controlled by the immune modulator interleukin 6 and normally supports the growth of cancer cells. The international research team discovered a missing link for an essential role of Stat3 and IL-6 signalling in prostate cancer progression.
Retired Senior Master Sgt. Leslie Howe has battled two cancers -- non-Hodgkin lymphoma and prostate cancer, both of which have been linked with exposure to Agent Orange, the herbicide used by the U.S. military to destroy enemy cover and crops during the Vietnam War. Show More Summary
Other topics include genetics to predict prostate cancer, Facebook and body image, bioengineered immune cell response, and more...
CAPE TOWN (Reuters) - Veteran South African anti-apartheid campaigner Desmond Tutu was discharged from hospital on Tuesday after a week fighting a persistent infection that is not related to his prostate cancer, his daughter said.
A set of genes could help stratify African American men in need of more aggressive treatment for prostate cancer.
Scientists have, for the first time, demonstrated the importance of sodium-dependent glucose transporters (SGLTs) in delivering glucose to pancreatic and prostate cancer cells. Their study results show promising evidence that current...Show More Summary